Innovation Pharmaceuticals Inc (IPIX)

[TOB]

That's just hyperbole.

Really, so a partnership is not a viable solution than being swallowed alive by the pink-sheets? OK, hopefully Leo's next PR will do the trick... -Rdunn88

"Swallowed alive by the pink-sheets?" Lol. The share price has declined due to more selling than buying. That it coincided with a 10 million share transfer to the float is a major clue to the clueless. (One would think)

That NASDAQ has used its discretion to keep the up-list pending has no doubt contributed to some short-term share price weakness.

The share price also appears to have found a bottom, and is if anything primed to rally. But really is only a concern to short-term traders or those trying to buy low.

Ultimately, for an investor, it is mere noise. CTIX is now multiples of its share price three years ago. It has also had higher swings and pull-backs. If the clinical trials continue with success, CTIX will be many multiples higher, with pull-backs on its way as all stocks do.

Why is "a partnership not a viable solution?", first, there is no solution needed. Cellceutix is in a position of strength with sufficient funding to complete Phase 3 for Brilacidin. The CEO has said any partnership must be at "spectacular" terms. Cellceutix has no need to partner on less than spectacular terms. The Brilacidin trial has a high probability of success and if so, will bring a terrific return for shareholders. So a terrific partnership is quite possible and likely, timed when it equals "spectacular". Brilacidin could also result in a buy-out with continued clinical success. Both will be well worth waiting for if they occur.

No PR or tricks are needed for the pending up-listing to NASDAQ. It is a highly probable event following the up-coming 10-K. Regardless, pipeline development and moving to Phase 3 should improve the share price, among other near-term catalysts. Sit back and watch the market play catch up. That's my plan.

Real value comes down the road upon success of the clinical trials. That is by no means certain, but it is the big reward if it occurs. With three drugs for 4 indications and increasing, I like the odds. But that's my personal plan and I do understand that others are looking to sell for a fraction along the way and are thus impatient. Good luck with that.

(Click to enlarge, graph shows tremendous corporate progress and increased potential)